An Open Label, Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects.

Trial Profile

An Open Label, Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2014

At a glance

  • Drugs Tasquinimod (Primary)
  • Indications Gynaecological cancer; Prostate cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top